Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,587 | -39,555 | -290,055 | -203,355 | -158,812 |
| Depreciation Amortization | 2,169 | 1,024 | 11,035 | 10,188 | 9,463 |
| Accounts receivable | N/A | -8,579 | 3,358 | N/A | N/A |
| Accounts payable and accrued liabilities | -9,435 | -11,724 | 4,831 | -5,850 | 690 |
| Other Working Capital | -35,488 | -30,873 | 66,258 | 27,456 | 31,366 |
| Other Operating Activity | 33,649 | 25,092 | -229 | 4,728 | 6,031 |
| Operating Cash Flow | $-105,692 | $-64,615 | $-204,802 | $-166,833 | $-111,262 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -96,151 | -145,981 | 40,593 | -572 | -17,737 |
| PPE Investments | -1,690 | -841 | 1,372 | 1,255 | 1,392 |
| Investing Cash Flow | $-97,841 | $-146,822 | $41,965 | $683 | $-16,345 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,406 | 8,869 | 260,969 | 3,898 | 2,781 |
| Other Financing Activity | -264 | -257 | 0 | 0 | 0 |
| Financing Cash Flow | $12,142 | $8,612 | $260,969 | $3,898 | $2,781 |
| Beginning Cash Position | 384,364 | 384,364 | 286,232 | 286,232 | 286,232 |
| End Cash Position | 192,973 | 181,539 | 384,364 | 123,980 | 161,406 |
| Net Cash Flow | $-191,391 | $-202,825 | $98,132 | $-162,252 | $-124,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,692 | -64,615 | -204,802 | -166,833 | -111,262 |
| Capital Expenditure | -1,734 | -857 | -1,776 | -1,737 | -1,057 |
| Free Cash Flow | -107,426 | -65,472 | -206,578 | -168,570 | -112,319 |